Evidence map›Paper›PMID 34795700›Full record

ArticleAfrican health sciences2021

Co-existence of NDM-1 and OXA-48 genes in Carbapenem Resistant

Ramadan Ahmed El-Domany, Tarek El-Banna, Fatma Sonbol, Samar Hamed Abu-Sayedahmed

Open access · diamondAbstract read
In one paragraph

Article in African health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Carbapenem and colistin-resistantJAC-antimicrobial resistance · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Infection and drug resistance · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Characterization of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  19. Carbapenem-ResistantInfection and drug resistance · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ramadan Ahmed El-DomanyDepartment of Microbiology and Immunology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt. ramadaneldomany@yahoo.com.
Tarek El-BannaDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta, Egypt. t_elbanna@yahoo.com.
Fatma SonbolDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta, Egypt. f_sonbol@yahoo.com.
Samar Hamed Abu-SayedahmedDepartment of Microbiology and Immunology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt. samarhamed580@yahoo.com.
Kafrelsheikh University · EGTanta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe noteworthy spread of carbapenem-resistant

objectiveDetermination of the carbapenemase genes incidence among CR-KP clinical isolates in Kafrelsheikh, Egypt.

methodsA total of 230

resultsOut of 230

conclusionThis study reported a high incidence of MDR profile with the emergence of blaNDM-1 and blaOXA-48 genes co-existence in CR-KP isolates in Kafrelsheikh, Egypt. Hence, more restrictions should be applied against the spread of such serious pathogens.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCarbapenemsEgyptHumansIncidenceKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-lactamase NDM-1beta-LactamasesCarbapenemsoxacillinaseblaNDM-1blaOXA-48carbapenem resistanceEgyptKlebsiella pneumoniaeMDRPCRsequencing

Identifiers

PMID34795700
PMCPMC8568246
OpenAlexW3188465156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.